{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:29:50Z","timestamp":1790519390821,"version":"4.1.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","award":["CUP H65E11000160005"],"award-info":[{"award-number":["CUP H65E11000160005"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00350","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T04:24:57Z","timestamp":1523420697000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":144,"title":["Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study"],"prefix":"10.3389","volume":"9","author":[{"given":"Claudia","family":"Giardina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola M.","family":"Cutroneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Mocciaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina T.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mandraffino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rapisarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosarita","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Arcoraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bcp.12293","article-title":"A systematic review of hospitalization resulting from medicine-related problems in adult patients.","volume":"78","author":"Al Hamid","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/art.23526","article-title":"Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal.","volume":"59","author":"Alacqua","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.eplepsyres.2009.03.002","article-title":"Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005.","volume":"85","author":"Alacqua","year":"2009","journal-title":"Epilepsy Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1136\/jech.2007.065227","article-title":"Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events.","volume":"62","author":"Aranaz-Andres","year":"2008","journal-title":"J. Epidemiol. Community Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40264-013-0019-9","article-title":"Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.","volume":"36","author":"Aronson","year":"2013","journal-title":"Drug Saf."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1503\/cmaj.1040498","article-title":"The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada.","volume":"170","author":"Baker","year":"2004","journal-title":"CMAJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1023\/A:1015570104121","article-title":"Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies.","volume":"24","author":"Beijer","year":"2002","journal-title":"Pharm. World Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s002280000260","article-title":"Analysis of the direct cost of adverse drug reactions in hospitalised patients.","volume":"56","author":"Bordet","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40264-015-0281-0","article-title":"Epidemiology of adverse drug reactions in Europe: a review of recent observational studies.","volume":"38","author":"Bouvy","year":"2015","journal-title":"Drug Saf."},{"key":"B10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/qshc.2002.003822","article-title":"Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I.","volume":"13","author":"Brennan","year":"2004","journal-title":"Qual. Saf. Health Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA).","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf."},{"key":"B12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/039463201302600132","article-title":"Overuse of prescription and OTC non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis.","volume":"26","author":"Cavagna","year":"2013","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","article-title":"Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.","volume":"277","author":"Classen","year":"1997","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/DHPS.S29287","article-title":"Adverse drug reactions in older patients: an Italian observational prospective hospital study.","volume":"4","author":"Conforti","year":"2012","journal-title":"Drug Healthc. Patient Saf."},{"key":"B16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/157488607779315507","article-title":"Adverse drug reactions in hospitals: a narrative review.","volume":"2","author":"Davies","year":"2007","journal-title":"Curr. Drug Saf."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.","volume":"4","author":"Davies","year":"2009","journal-title":"PLoS One"},{"key":"B18","first-page":"267","article-title":"Iatrogenic illness in a department of general internal medicine: a prospective study.","volume":"56","author":"de la Sierra","year":"1989","journal-title":"Mt. Sinai J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2165\/11592030-000000000-00000","article-title":"Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.","volume":"34","author":"Dequito","year":"2011","journal-title":"Drug Saf."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.7150\/ijms.6640","article-title":"Which adverse events are related to health care during hospitalization in elderly inpatients?","volume":"10","author":"Dupouy","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"B21","year":"2014","journal-title":"Guideline on Good Pharmacovigilance Practices (GVP): Annex 1. EMA\/876333\/2011 Rev 4"},{"key":"B22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ejim.2010.05.014","article-title":"Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania.","volume":"21","author":"Farcas","year":"2010","journal-title":"Eur. J. Intern. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.revmed.2006.01.017","article-title":"[Adverse drug related events in a postemergency unit: prospective cohort study with 6 months follow up].","volume":"27","author":"Fauchais","year":"2006","journal-title":"Rev. Med. Interne"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102146","article-title":"Pattern of statin use in southern Italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?","volume":"9","author":"Ferrajolo","year":"2014","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2165\/00002018-200831060-00009","article-title":"Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.","volume":"31","author":"Franceschi","year":"2008","journal-title":"Drug Saf."},{"key":"B26","first-page":"1129","article-title":"[Adverse drug reactions among hospitalized elderly patients. Prospective study].","volume":"125","author":"Gonzalez-Martin","year":"1997","journal-title":"Rev. Med. Chil."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033236","article-title":"Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions\u2013a meta-analysis.","volume":"7","author":"Hakkarainen","year":"2012","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.5414\/CP201514","article-title":"Adverse drug reactions (ADRs) associated with hospital admissions - elderly female patients are at highest risk.","volume":"49","author":"Hofer-Dueckelmann","year":"2011","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/qhc.12.4.280","article-title":"Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study.","volume":"12","author":"Howard","year":"2003","journal-title":"Qual. Saf. Health Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","article-title":"Which drugs cause preventable admissions to hospital? A systematic review.","volume":"63","author":"Howard","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089072","article-title":"The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy.","volume":"9","author":"Ingrasciotta","year":"2014","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122899","article-title":"Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study.","volume":"10","author":"Ingrasciotta","year":"2015","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/bcp.12577","article-title":"Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.","volume":"79","author":"Italiano","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1345\/aph.1L037","article-title":"Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.","volume":"42","author":"Kongkaew","year":"2008","journal-title":"Ann. Pharmacother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s002280050738","article-title":"Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.","volume":"56","author":"Lagnaoui","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"B37","first-page":"1890","article-title":"Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.","volume":"168","author":"Leendertse","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ejim.2006.12.009","article-title":"The diseases we cause: iatrogenic illness in a department of internal medicine.","volume":"18","author":"Madeira","year":"2007","journal-title":"Eur. J. Intern. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-2125.1998.00817.x","article-title":"Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies.","volume":"46","author":"Martin","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1345\/aph.1A333","article-title":"Hospital admissions resulting from preventable adverse drug reactions.","volume":"36","author":"McDonnell","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/pds.667","article-title":"Adverse drug reactions as a cause for admissions to a department of internal medicine.","volume":"11","author":"Mjorndal","year":"2002","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B42","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/pds.1916","article-title":"Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients.","volume":"19","author":"Mohebbi","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amjopharm.2006.03.002","article-title":"Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents.","volume":"4","author":"Nguyen","year":"2006","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00228-010-0977-0","article-title":"Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study.","volume":"67","author":"Nobili","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","article-title":"Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA).","volume":"50","author":"Onder","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1365-2125.2010.03619.x","article-title":"Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07.","volume":"70","author":"Oteri","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.farma.2010.08.003","article-title":"Adverse drug reactions which provoke hospital admission.","volume":"35","author":"Perez Menendez-Conde","year":"2011","journal-title":"Farm. Hosp."},{"key":"B49","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00228-005-0972-z","article-title":"Statin-macrolide interaction risk: a population-based study throughout a general practice database.","volume":"61","author":"Piacentini","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"B51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/0394632015599705","article-title":"Allopurinol-induced Sweet\u2019s syndrome.","volume":"29","author":"Polimeni","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/pds.1663","article-title":"Adverse drug reactions in patients in an Iranian department of internal medicine.","volume":"18","author":"Pourseyed","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.diabres.2014.12.007","article-title":"Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: a population-based study.","volume":"108","author":"Rafaniello","year":"2015","journal-title":"Diabetes. Res. Clin. Pract."},{"key":"B55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2165\/11599430-000000000-00000","article-title":"Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands.","volume":"29","author":"Ruiter","year":"2012","journal-title":"Drugs Aging"},{"key":"B56","first-page":"457","article-title":"[A iatrogenic pathology study in an internal medicine service].","volume":"194","author":"Sampereiz Legarre","year":"1994","journal-title":"Rev. Clin. Esp."},{"key":"B57","article-title":"Focusing on the preventability of adverse drug reactions.","volume":"27","author":"Schumock","year":"1992","journal-title":"Hosp. Pharm."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/187103","article-title":"Sex differences in drug disposition.","volume":"2011","author":"Soldin","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1001\/jama.2010.1482","article-title":"Managing medications in clinically complex elders: \u201cThere\u2019s got to be a happy medium\u201d.","volume":"304","author":"Steinman","year":"2010","journal-title":"JAMA"},{"key":"B60","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.4103\/0976-500X.120957","article-title":"Clinical and economic burden of adverse drug reactions.","volume":"4","author":"Sultana","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/bmj.320.7237.741","article-title":"Incidence and types of preventable adverse events in elderly patients: population based review of medical records.","volume":"320","author":"Thomas","year":"2000","journal-title":"BMJ"},{"key":"B62","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00228-007-0459-1","article-title":"Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision.","volume":"64","author":"Trifiro","year":"","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-2125.2006.02687.x","article-title":"Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources.","volume":"62","author":"Trifiro","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.parkreldis.2007.10.010","article-title":"Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003-2005.","volume":"14","author":"Trifiro","year":"","journal-title":"Parkinsonism Relat. Disord."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/268362","article-title":"Chronic kidney disease requiring healthcare services: a new approach to evaluate epidemiology of renal disease.","volume":"2014","author":"Trifiro","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B66","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/pds.1565","article-title":"Adverse drug reaction-related hospitalisations: a population-based cohort study.","volume":"17","author":"van der Hooft","year":"2008","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2165\/00002018-200629020-00006","article-title":"Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.","volume":"29","author":"van der Hooft","year":"2006","journal-title":"Drug Saf."},{"key":"B68","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00228-008-0494-6","article-title":"Women encounter ADRs more often than do men.","volume":"64","author":"Zopf","year":"","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B69","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2165\/00002018-200831090-00007","article-title":"Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals.","volume":"31","author":"Zopf","year":"","journal-title":"Drug Saf."},{"key":"B70","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000248311","article-title":"Gender-based differences in drug prescription: relation to adverse drug reactions.","volume":"84","author":"Zopf","year":"2009","journal-title":"Pharmacology"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00350\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T04:25:04Z","timestamp":1523420704000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00350\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":70,"alternative-id":["10.3389\/fphar.2018.00350"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00350","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,11]]},"article-number":"350"}}